ArticleAmerican journal of cancer research2022

A novel tumor-specific broad-spectral monoclonal antibody to PL2L60 is highly effective for the treatment of various types of cancers from human and mouse.

Hong-Min Lu et al.PubMed ↗Full text ↗

No numbers read from the abstract.